Home/Filings/4/0001209191-21-039897
4//SEC Filing

Miller Ann Calby 4

Accession 0001209191-21-039897

CIK 0001401667other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 4:59 PM ET

Size

5.2 KB

Accession

0001209191-21-039897

Insider Transaction Report

Form 4
Period: 2021-06-10
Transactions
  • Sale

    COMMON STOCK

    2021-06-10$11.43/sh12,874$147,15612,874 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.36 to $11.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

PUMA BIOTECHNOLOGY, INC.

CIK 0001401667

Entity typeother

Related Parties

1
  • filerCIK 0001771423

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 4:59 PM ET
Size
5.2 KB